{
  "docId": "019de074-c89a-7228-80c7-3305707f7e50",
  "docSlug": "2a632d1edd5f737186449d0c40369511",
  "documentTitle": "AbCellera | Investor Presentation Deck | 20 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 20,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "context",
  "function": "establish_context",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The chart illustrates the 'valley of death' in drug development, highlighting the low probability of success (POS) and the long timeline to commercialization.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-c89a-7228-80c7-3305707f7e50/5",
  "deckHref": "/decks/019de074-c89a-7228-80c7-3305707f7e50",
  "deckJsonHref": "/decks/019de074-c89a-7228-80c7-3305707f7e50.json",
  "deckAnchorHref": "/decks/019de074-c89a-7228-80c7-3305707f7e50#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.08,
        "x": 0.78,
        "y": 0.09
      },
      "kind": "callout",
      "text": "Peak sales ~$1B",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "41354c72-3452-416f-9e96-4374af1de8de",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.08,
        "x": 0.5,
        "y": 0.59
      },
      "kind": "callout",
      "text": "POS: >5%",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e6827df8-0a23-4aba-adc7-4a05dd365ac8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.82,
        "x": 0.09,
        "y": 0.28
      },
      "kind": "chart",
      "text": "Investment profile over 21 years",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5e6a11d7-e25d-43ac-9590-fae5347128dc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.35,
        "x": 0.21,
        "y": 0.29
      },
      "kind": "chart",
      "text": "Risk/Investment curve",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8fa7fd5f-7357-45d1-8b4a-4133ffd6aaa1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.35,
        "x": 0.09,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "Illustrative drug development investment profile:",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "35dc7c9e-c755-4d3f-8474-a66d75f2cb99",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.82,
        "x": 0.09,
        "y": 0.87
      },
      "kind": "table",
      "text": "Stage of program development: Discovery to IND, Phase 1-3, Commercial Sales",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b1c0808c-9c14-4058-9739-256b32b188a9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.6,
        "x": 0.09,
        "y": 0.06
      },
      "kind": "title",
      "text": "TECHNOLOGY CAN MAKE A BIG IMPACT ON PRODUCT CREATION.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "099e86b8-c29f-483c-b8c8-6f82ebbed97b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "d43a843d-a54b-43c5-adcf-598e92212e37",
      "evidence": "This slide contains various charts, including a bar chart and a line chart.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "drug-development-lifecycle",
      "slug": null,
      "matchId": "a2750146-0014-4b36-8f7c-395c2b290518",
      "evidence": "The slide maps investment and risk against standard drug development phases (Discovery, Phase 1-3, Commercial).",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 5,
      "from": 4,
      "beatId": "ce4c3757-7e42-4174-b40c-9a393c3b6759",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "Slides 4 and 5 discuss the drug development process and the impact of technology on product creation.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 4,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "d5aef738-c13e-4700-a5e0-144a4530e1cf",
      "evidence": "Slides 4 and 5 imply that current methods are not optimal, setting up the need for AbCellera's solution.",
      "position": 0,
      "objective": "Highlight the need for improved antibody discovery and development.",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 7,
      "from": 3,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "ccd08fb1-5266-40b1-a431-23de1500c550",
      "evidence": "Slides 3 and 7 discuss AbCellera's mission and vision, which align with the Golden Circle loop.",
      "position": 1,
      "objective": "Explain why AbCellera's approach is valuable.",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}